Last Updated on February 9, 2022 by The Health Master
First nasal spray for COVID-19 treatment in India
For the treatment of adult patients suffering from COVID-19, pharmaceutical company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India.
The nasal spray was launched by the pharma company in partnership with SaNOtize. “The Phase 3 trial in India met the key endpoints and demonstrated a reduction of viral load of 94 percent in 24 hours and 99 percent in 48 hours.”
The Nitric Oxide Nasal Spray (NONS) was safe and well-tolerated. Glenmark to market NONSFabiSpray, brand name FabiSpray,” the company said in a statement.
10 things to know:
1) Nitric Oxide Nasal Spray (FabiSpray) will be useful in the treatment of adult patients with COVID-19 who have a high risk of progression of the disease.
2) FabiSpray, Nitric Oxide Nasal Spray (NONS), according to Glenmark, is designed to kill the COVID-19 virus in the upper airways.
3) It has proven anti-microbial properties with a direct virucidal effect on SARS-CoV-2. NONS when sprayed over the nasal mucosa
4) It acts as a physical and chemical barrier against the virus, preventing it from incubating and spreading to the lungs, the company explained.
5) FabiSpray has been developed for the treatment of adult patients of Covid-19 who have a high risk of progression of the disease.
6) Terming the spray an effective and safe antiviral treatment for COVID-19, Glenmark Pharmaceuticals Ltd’s Chief Commercial Officer Robert Crockart said “we are confident it will offer patients a much needed and timely therapy option.”
7) The Phase 3 trials of the spray in India demonstrated a reduction of viral load by 94 per cent in 24 hours and 99 per cent in 48 hours.
8) Glenmark received manufacturing and marketing approval from India’s drug regulator, Drugs Controller General of India, for Nitric Oxide Nasal Spray as part of the accelerated approval process.
9)”In the current scenario, with new emerging variants exhibiting high transmissibility, NONS provides a useful option in India’s fight against COVID-19,” said Dr Monika Tandon, Senior VP and Head of Clinical Development in Glenmark Pharmaceuticals Ltd.
10) “As per studies conducted in the Utah State University USA, NONS is proven to kill 99.9 per cent of SARS-Cov-2 virus including Alpha, Beta, Gamma, Delta, and Epsilon variant within 2 minutes.” she said.
CDSCO gives nod to Wockhardt to export Sputnik vaccines
DCGI gives nod to manufacture vaccine against omicron for test and…
Overprescription back under spotlight: Doctors
IPC to include Dissolution Test in prolonged-release formulations in IP
India and Pharmacy Education: Chapter: 14
Antibiotic resistance: A hidden threat behind Covid
DCGI grants emergency use permission to single-dose Sputnik Light vaccine
Govt gives nod for Medical Device park in Solan
Proposal submitted to DCGI to test Sputnik Light as booster dose: Dr Reddy’s
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
